Boeing Delivered 51 Jets in August. Here's Why the Stock is Finally Back Above $200.

Boeing reported Q2 revenue of $24.5 billion, up 8% year over year, and adjusted free cash flow of $631 million, reversing a $200 million outflow in the prior-year quarter. Its $715 billion backlog includes more than 6,200 commercial aircraft, supporting substantial revenue visibility despite August deliveries falling 10.5% year over year to 51 aircraft. Shares recently exceeded $200 but remain down more than 5% year to date, with execution, delivery timing, stakeholder trust, and capital-spending discipline remaining key risks.

Analysis

BA’s valuation inflection depends less on backlog size than on whether production normalization converts customer advances into repeatable free cash flow without renewed quality costs, supplier concessions, or working-capital reversals. A single positive quarter of adjusted FCF is not yet evidence of a self-funding recovery: the key sensitivity is sustained delivery cadence through the next two quarters and whether commercial-aircraft margins recover as rework and abnormal costs roll off. The near-term stock reaction is likely capped after the move above $200 unless monthly deliveries reaccelerate and management provides cleaner cash-conversion visibility.

The second-order beneficiary of a credible Boeing rate ramp is the aerospace supply chain—GE Aerospace (GE), RTX and Hexcel (HXL) have operating leverage to higher installed production, while airlines with Boeing-heavy fleet plans, including Southwest (LUV), gain capacity certainty and reduce expensive aircraft-substitution or schedule constraints. Conversely, Airbus (EADSY) loses some scarcity premium only if Boeing’s output recovery proves durable; constrained engine and aerostructure capacity means Boeing cannot rapidly erase years of delivery disruption. For 6-18 months, the more important competitive variable is whether Boeing can improve output without forcing suppliers to carry uneconomic inventory or triggering another regulator-driven production pause.

Consensus appears to be assigning substantial credit to the turnaround before independently verifiable margin recovery. The underappreciated downside is that a modest delivery miss can have an outsized cash effect because inventory, customer compensation and supplier payment timing all move together; this makes BA a poor vehicle for investors seeking linear exposure to commercial aviation demand. Falsify a cautious stance if Boeing posts two consecutive quarters of positive operating cash flow and raises its full-year delivery or cash outlook without a corresponding increase in abnormal charges; conversely, any renewed FAA constraint, supplier disruption, or downward delivery guidance should compress the recovery multiple quickly.

Key Decisions for Investors

• Do not chase BA above $200 on delivery headlines; build only on a 10-15% pullback or after the next earnings release confirms positive operating cash flow, not merely adjusted FCF. Upside requires a multi-quarter margin and rate recovery, while downside is asymmetric if guidance is cut.
• For a 3-6 month aerospace-cycle expression, prefer a modest long GE / short BA pair after confirming Boeing production-rate stability. GE captures incremental engine aftermarket and OEM volumes with less company-specific certification, quality and balance-sheet risk; exit if Boeing raises delivery guidance materially or GE’s LEAP supply commentary deteriorates.
• Maintain an alert on BA monthly deliveries and quarterly inventory/cash conversion: a second consecutive monthly delivery decline combined with no improvement in cash flow is a trigger to buy 3-6 month BA downside protection or reduce exposure. The thesis is invalidated by sustained delivery improvement plus clean guidance reaffirmation.
• Watch LUV as a derivative beneficiary rather than an immediate long: improved Boeing delivery reliability over the next 6-12 months would reduce fleet-planning friction, but initiate only if management quantifies capacity restoration or reduced aircraft-delay costs. Without that disclosure, the benefit remains narrative rather than earnings-visible.